Structural Requirements of Acetylcholinesterase Reactivators

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-03 ,pp. : 269-277

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro Potency of H Oximes (HI-6, HLö-7), the Oxime BI-6, and Currently Used Oximes (Pralidoxime, Obidoxime, Trimedoxime) to Reactivate Nerve Agent-Inhibited Rat Brain Acetylcholinesterase

By Kuca Kamil   Cabal Jiri   Kassa Jiri   Jun Daniel   Hrabinova Martina  

Journal of Toxicology and Environmental Health, Vol. 69, Iss. 15, 2006-09 ,pp. : 1431-1440

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Comparison of the Potency of Newly Developed Oximes (K005, K027, K033, K048) and Currently Used Oximes (Pralidoxime, Obidoxime, HI-6) to Reactivate Sarin-Inhibited Rat Brain Acetylcholinesterase By in Vitro Methods

By Kuca Kamil   Cabal Jiri   Kassa Jiri  

Journal of Toxicology and Environmental Health, Vol. 68, Iss. 8, 2005-01 ,pp. : 677-686

Taylor & Francis Ltd

Access to resources Recommend Favorite

Potency of HI-6 to Reactivate Cyclosarin, Soman and Tabun Inhibited Acetylcholinesterase - In Vivo Study

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 7, 2010-08 ,pp. : 516-520

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicological considerations of acetylcholinesterase reactivators

By Voicu Victor   Rădulescu Flavian Ştefan   Medvedovici Andrei  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 31-50

Informa Healthcare

Access to resources Recommend Favorite